INSIGHTS ON CONTRACT PHARMA MANUFACTURING
-
![60-Seconds of Science: Optimizing Complex Molecule Production]( "60-Seconds Of Science: Optimizing Complex Molecule Production")
60-Seconds Of Science: Optimizing Complex Molecule ProductionA principal scientist shares how his team overcame key manufacturing challenges in complex bispecific antibody production, highlighting problem-solving strategies and impressive results in this concise educational video.
-
![GettyImages-2194013442-laboratory-scientists-computer-evaluating]( "60-Seconds Of Science")
60-Seconds Of ScienceExplore the complex biologics journey, featuring expert-led discussions on development, analytics, MSAT, and tech transfer, offering concise, practical insights for busy professionals worldwide.
-
![GettyImages-2182383108-ADC-manufacturing-scientist]( "Advancing ADCs With Expertise In Payloads And Linkers")
Advancing ADCs With Expertise In Payloads And LinkersDiscover how integrated containment, high-potency expertise, advanced chromatography, and proven linker–payload process optimization can accelerate your ADC program from early development to reliable commercial supply.
-
![sialic-acid-GettyImages-1497108072]( "MS/MS For Confident Sialic Acid ID")
MS/MS For Confident Sialic Acid IDMS/MS distinguishes isobaric sialic acids to confirm safe glycan structures, reduce immunogenic risk, and boost confidence in late‑stage biologics before review.
-
![Picture2]( "How To Fast-Track Your Oral Solid Dose To Phase 1")
How To Fast-Track Your Oral Solid Dose To Phase 1A strategic approach accelerates oral solid dose development by uniting molecular analysis, solubility improvement, formulation design, manufacturing efficiency, and stability testing to reach Phase 1 faster.
-
![GettyImages-2217581928 manufacturing, production]( "Practical USP <1665>/<665> Guide To E&L Risk Assessment")
Practical USP <1665>/<665> Guide To E&L Risk AssessmentA practical USP <1665> and <665> framework helps manufacturers evaluate and manage extractables and leachables risk, supporting quality, safety, and regulatory compliance.
-
![GettyImages-1404945060-lab-process-cleanroom-research]( "Monitoring, Media Fills, And QC: Demonstrating Sterility Assurance At Your CDMO")
Monitoring, Media Fills, And QC: Demonstrating Sterility Assurance At Your CDMOCDMO guide on environmental monitoring, media fills, and QC to prove sterility assurance in aseptic manufacturing—key elements of the Contamination Control Strategy beyond facility design.
-
![GettyImages-2183428971-lab-cleanroom]( "EU Annex 1: Building Modern CDMO Sterile Fill/Finish Facilities")
EU Annex 1: Building Modern CDMO Sterile Fill/Finish FacilitiesA CDMO guide to implementing EU Annex 1 for modern sterile fill/finish facilities, covering cleanroom design, contamination control, utilities, personnel, monitoring, and audit essentials.
-
![GettyImages-2178829362-glp-1-protein-3d-render]( "The Adenovirus Revolution In Cancer Treatment")
The Adenovirus Revolution In Cancer TreatmentAdenoviruses are being reimagined as powerful tools for oncolytic cancer therapy, using their immunogenicity, tumor selectivity, and synergy with immunotherapy to drive new clinical progress.
-
![Beyond Solid Phase Synthesis]( "Beyond Solid Phase Synthesis")
Beyond Solid Phase SynthesisExplore how enzymatic methods, real-time analytics, and AI optimization enhance long-sequence TIDES, improving control, speeding timelines, and supporting sustainable production.
